Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials
Sign Up to like & getrecommendations! Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.26711
Abstract: Lesion length has been an important factor in predicting a worse outcome after percutaneous coronary interventions (PCI); however, the safety and efficacy of second‐generation drug eluting stents in very long coronary lesions has not been… read more here.
Keywords: treatment long; clinical outcomes; xience; pci treatment ... See more keywords
Novel anaerobic membrane bioreactor (AnMBR) design for wastewater treatment at long HRT and high solid concentration.
Sign Up to like & getrecommendations! Published in 2018 at "Bioresource technology"
DOI: 10.1016/j.biortech.2017.11.025
Abstract: Performance of two novel designed anaerobic membrane bioreactor (AnMBRs) for wastewater treatment at long hydraulic retention time (HRT, 47 days) and high sludge concentration (22 g·L-1) was investigated. Results showed steady chemical oxygen demand (COD) removal (>98%)… read more here.
Keywords: treatment long; anaerobic membrane; wastewater treatment; membrane bioreactor ... See more keywords
Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease.
Sign Up to like & getrecommendations! Published in 2017 at "World neurosurgery"
DOI: 10.1016/j.wneu.2017.01.055
Abstract: OBJECTIVE To elucidate the clinical features, surgical treatment, and long-term outcome in elderly patients with moyamoya disease (MMD). METHODS We retrospectively reviewed 87 elderly patients with MMD at Beijing Tiantan Hospital. Clinical features, radiologic findings,… read more here.
Keywords: treatment long; surgical treatment; clinical features; mmd ... See more keywords
Impact of oncotype Dx score on treatment and long-term outcomes.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e12518
Abstract: e12518Background: Oncotype dx is a 21 gene breast cancer assay that helps predict benefit of chemotherapy in early-stage hormone receptor positive (HR+), HER2 negative, 0 to 3 node positive breast ... read more here.
Keywords: impact oncotype; oncotype score; term outcomes; long term ... See more keywords